Medtronic officials today said that the company's planned separation of its Diabetes business is on the right track.

Jellison currently serves as a Senior Advisor for Astor Place Holdings, the Private Equity arm of Select Equities, and ...

Medtronic said on Tuesday it would add two new directors to its board and set up committees to help boost its lagging shares ...

“Our decision to become one of Medtronic’s largest investors was driven by our strong conviction that the company is entering ...

A clutch of post-earnings price target increases by analysts helped raise Medtronic 's (NYSE: MDT) stock at a healthy rate on ...

"Are we investing enough behind these big growth drivers? We think no. We want to invest more," Medtronic CEO Geoff Martha ...

Citi analyst Joanne Wuensch raised the firm’s price target on Medtronic (MDT) to $101 from $99 and keeps a Buy rating on the shares. The firm ...

Medtronic has agreed to not only expand the size of its board of directors, but to also task it with taking a closer look at ...

Medtronic posted better-than-expected earnings, lifted its sales forecast, and faces analyst debate on growth prospects and ...

CEO Geoff Martha told investors that the initiatives were done in partnership with the activist investor firm Elliott ...

Medtronic appoints two new board directors following talks with activist investor Elliott Investment Management.

FQ1 results and guidance update did not spark a rally in the share price. Still, they did affirm a robust outlook that ...